Literature DB >> 21349338

Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study.

Andrew P Prescot1, Allison E Locatelli2, Perry F Renshaw3, Deborah A Yurgelun-Todd4.   

Abstract

Converging evidence from neuroimaging and neuropsychological studies indicates that heavy marijuana use is associated with cingulate dysfunction. However, there has been limited human data documenting in vivo biochemical brain changes after chronic marijuana exposure. Previous proton magnetic resonance spectroscopy studies have demonstrated reduced basal ganglia glutamate and dorsolateral prefrontal cortex N-acetyl aspartate levels in adult chronic marijuana users. Similar studies have not been reported in adolescent populations. The present study used proton magnetic resonance spectroscopy to determine whether reductions in glutamate, N-acetyl aspartate and/or other proton metabolite concentrations would be found in the anterior cingulate cortex (ACC) of adolescent marijuana users compared with non-using controls. Adolescent marijuana users (N=17; average age 17.8 years) and similarly aged healthy control subjects (N=17; average age 16.2 years) were scanned using a Siemens 3T Trio MRI system. Proton magnetic resonance spectroscopy data were acquired from a 22.5 mL voxel positioned bilaterally within the ACC. Spectra were fitted using commercial software and all metabolite integrals were normalized to the scaled unsuppressed water integral. Analysis of variance and analysis of covariance were performed to compare between-group metabolite levels. The marijuana-using cohort showed statistically significant reductions in anterior cingulate glutamate (-15%, p<0.01), N-acetyl aspartate (-13%, p=0.02), total creatine (-10%, p<0.01) and myo-inositol (-10%, p=0.03). Within-voxel tissue-type segmentation did not reveal any significant differences in gray/white matter or cerebrospinal fluid content between the two groups. The reduced glutamate and N-acetyl aspartate levels in the adolescent marijuana-using cohort are consistent with precedent human (1)H MRS data, and likely reflect an alteration of anterior cingulate glutamatergic neurotransmission and neuronal integrity within these individuals. The reduced total creatine and myo-inositol levels observed in these subjects might infer altered ACC energetic status and glial metabolism, respectively. These results expand on previous functional MRI data reporting altered cingulate function in individuals with marijuana-abuse.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21349338      PMCID: PMC3101285          DOI: 10.1016/j.neuroimage.2011.02.044

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  42 in total

1.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.

Authors:  Y Zhang; M Brady; S Smith
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

2.  Proton NMR chemical shifts and coupling constants for brain metabolites.

Authors:  V Govindaraju; K Young; A A Maudsley
Journal:  NMR Biomed       Date:  2000-05       Impact factor: 4.044

3.  Dose-related neurocognitive effects of marijuana use.

Authors:  K I Bolla; K Brown; D Eldreth; K Tate; J L Cadet
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

4.  Chronic cannabis users show altered neurophysiological functioning on Stroop task conflict resolution.

Authors:  Robert A Battisti; Steven Roodenrys; Stuart J Johnstone; Nicole Pesa; Daniel F Hermens; Nadia Solowij
Journal:  Psychopharmacology (Berl)       Date:  2010-08-19       Impact factor: 4.530

5.  A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations.

Authors:  J C Brooks; N Roberts; G J Kemp; M A Gosney; M Lye; G H Whitehouse
Journal:  Cereb Cortex       Date:  2001-07       Impact factor: 5.357

6.  Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia.

Authors:  G Ende; D F Braus; S Walter; W Weber-Fahr; B Soher; A A Maudsley; F A Henn
Journal:  Schizophr Res       Date:  2000-02-14       Impact factor: 4.939

7.  In vivo quantitative proton MRSI study of brain development from childhood to adolescence.

Authors:  Alena Horská; Walter E Kaufmann; Larry J Brant; Sakkubai Naidu; James C Harris; Peter B Barker
Journal:  J Magn Reson Imaging       Date:  2002-02       Impact factor: 4.813

Review 8.  1H MR spectroscopy of brain tumours and masses.

Authors:  Franklyn A Howe; Kirstie S Opstad
Journal:  NMR Biomed       Date:  2003-05       Impact factor: 4.044

9.  Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers.

Authors:  N Hájos; T F Freund
Journal:  Neuropharmacology       Date:  2002-09       Impact factor: 5.250

10.  Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors.

Authors:  Alexander F Hoffman; Nora Laaris; Masahito Kawamura; Susan A Masino; Carl R Lupica
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

View more
  38 in total

1.  Phase-adjusted echo time (PATE)-averaging 1 H MRS: application for improved glutamine quantification at 2.89 T.

Authors:  Andrew P Prescot; Todd Richards; Stephen R Dager; Changho Choi; Perry F Renshaw
Journal:  NMR Biomed       Date:  2012-03-12       Impact factor: 4.044

Review 2.  Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review.

Authors:  Eric A Woodcock; Ansel T Hillmer; Graeme F Mason; Kelly P Cosgrove
Journal:  Mol Neuropsychiatry       Date:  2019-05-09

Review 3.  Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity.

Authors:  Scott J Moeller; Edythe D London; Georg Northoff
Journal:  Neurosci Biobehav Rev       Date:  2015-12-01       Impact factor: 8.989

4.  Olfactory Neuroepithelium Cells from Cannabis Users Display Alterations to the Cytoskeleton and to Markers of Adhesion, Proliferation and Apoptosis.

Authors:  Alejandra Delgado-Sequera; María Hidalgo-Figueroa; Marta Barrera-Conde; Mª Carmen Duran-Ruiz; Carmen Castro; Cristina Fernández-Avilés; Rafael de la Torre; Ismael Sánchez-Gomar; Víctor Pérez; Noelia Geribaldi-Doldán; Patricia Robledo; Esther Berrocoso
Journal:  Mol Neurobiol       Date:  2020-11-25       Impact factor: 5.590

5.  Two-dimensional J-resolved proton MR spectroscopy and prior knowledge fitting (ProFit) in the frontal and parietal lobes of healthy volunteers: assessment of metabolite discrimination and general reproducibility.

Authors:  Andrew P Prescot; Perry F Renshaw
Journal:  J Magn Reson Imaging       Date:  2012-10-10       Impact factor: 4.813

6.  Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.

Authors:  Christian Núñez; Susana Ochoa; Elena Huerta-Ramos; Iris Baños; Ana Barajas; Montserrat Dolz; Bernardo Sánchez; Núria Del Cacho; Judith Usall
Journal:  Psychopharmacology (Berl)       Date:  2015-12-01       Impact factor: 4.530

Review 7.  Effects of cannabis on the adolescent brain.

Authors:  Joanna Jacobus; Susan F Tapert
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy.

Authors:  Shelli R Kesler; Christa Watson; Della Koovakkattu; Clement Lee; Ruth O'Hara; Misty L Mahaffey; Jeffrey S Wefel
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

9.  γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers.

Authors:  Andrew P Prescot; Perry F Renshaw; Deborah A Yurgelun-Todd
Journal:  Drug Alcohol Depend       Date:  2013-03-21       Impact factor: 4.492

10.  Prior exposure to THC increases the addictive effects of nicotine in rats.

Authors:  Leigh V Panlilio; Claudio Zanettini; Chanel Barnes; Marcelo Solinas; Steven R Goldberg
Journal:  Neuropsychopharmacology       Date:  2013-01-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.